Presented at the Twenty-third Annual Meeting of the American Association for the Study of Headache. Washington, D.C., June 19-21, 1981.
Change in Platelet Taurine and Migraine†
Version of Record online: 22 JUN 2005
Headache: The Journal of Head and Face Pain
Volume 22, Issue 4, pages 165–166, July 1982
How to Cite
Dhopesh, V.P. and Baskin, S.I. (1982), Change in Platelet Taurine and Migraine. Headache: The Journal of Head and Face Pain, 22: 165–166. doi: 10.1111/j.1526-4610.1982.hed2204165.x
- Issue online: 22 JUN 2005
- Version of Record online: 22 JUN 2005
- Accepted for Publication: October 13, 1981
- Cited By
To establish if other neuromodulators exhibit abnormal metabolism in the platelet during migraine, we sought to analyze taurine levels, a neuromodulator known to be actively accumulated by the platelet. It was found that taurine platelet levels were greater during the headache phase (p<0.01) than the postictal phase. We propose that the metabolic platelet defect in migraine extends beyond a singular chemical species, i.e., serotonin, but may involve other substances such as taurine.